Summary: Researchers at Lobachevsky University are developing a neurochip designed to restore communication between healthy brain cells and damaged or non-functioning areas. Initial laboratory experiments show successful transmission of signals from electronic, artificial neurons to living brain tissue.
Source: Lobachevsky University.
Lobachevsky University Develops a Neurochip to Restore Brain Signaling
Scientists at Lobachevsky University’s Radiophysics Faculty are advancing a neurochip technology intended to reestablish electrical signaling in regions of the brain that have been injured or have ceased functioning correctly. The research team reports that, in initial experiments, they were able to transmit a signal from an artificial neuron to living cells in a brain slice, demonstrating a functional interface between synthetic and biological neurons.
The team, composed of physicists, engineers, and neuroscientists, is working toward producing a scalable artificial neural network implemented on a neurochip. Their near-term objective is to build a network of at least 100 artificial nerve cells within three years. This network would serve as the foundation for devices aimed at replacing or bypassing damaged brain tissue and restoring lost signal transmission.
Mikhail Mishchenko, a research assistant at the Radiophysics Faculty, emphasizes that the key challenge ahead is to fully understand the mechanisms by which artificial elements can replace damaged neurons and reliably transmit signals to neighboring cells. “Many forms of paralysis and neural dysfunction arise when parts of the nervous system stop transmitting signals correctly,” Mishchenko explains. “Our goal with artificial chips is to restore that lost transmission so that functional pathways can be rebuilt or bypassed.”
The researchers have already designed and tested a prototype electronic neuron under laboratory conditions. Measurements indicate that the electrical oscillations produced by the artificial neuron closely match the kinds of electrical activity observed in biological neurons. Matching these dynamic properties is crucial because the timing and pattern of electrical signals determine how information is processed and propagated within neural circuits.
Once the team completes a functional artificial neural network on a chip, the next phase will be pre-clinical testing. These tests are planned to take place at Lobachevsky University using animal models. The primary objective of pre-clinical trials is to demonstrate that implanted neurochip systems can restore or reestablish electrical pulses in regions of the brain that have sustained damage, ultimately leading to functional improvement.
Research Goals and Path Forward
The project combines electronic engineering, computational modeling, and experimental neuroscience. Short-term goals include scaling up the number of artificial neurons, improving the stability of their oscillatory behavior, and perfecting the interface that connects artificial elements to living tissue. Medium-term goals involve safety testing, reproducibility studies, and establishing protocols for implantation and long-term operation. The researchers frame these steps as necessary milestones before any clinical applications can be considered.
Developing neurochips that can seamlessly communicate with biological neurons requires careful attention to biocompatibility, signal fidelity, and the ability to adapt to changing neural environments. The Lobachevsky University team is addressing these issues by refining the electronic neuron design, improving signal-processing algorithms that control timing and patterning, and conducting controlled laboratory experiments to verify stable interfacing with brain tissue.
Source: Nikita Avralev, Lobachevsky University
Publisher: Organized by NeuroscienceNews.com (original reporting)
Image Source: Image in the public domain.
Original Research: The study is slated to appear in the journal Technical Physics Letters.
This report summarizes the current status of a developing neurochip technology based on information provided by the research team. The work remains at the laboratory and pre-clinical planning stages; further research, validation, and safety testing are required before any clinical use. Feel free to share this summary of the research while respecting source attribution.